Cytosorbents (CTSO) Misses Q2 EPS by 3c

August 9, 2016 5:28 PM EDT
Get Alerts CTSO Hot Sheet
Trade CTSO Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $2.18 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment